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Policingis one ofthe mostdangerous and stressful occupations and suchstress can havedeleterious eﬀects on health. The purpose
of this study was to examine the associationbetween depressive symptoms and metabolic syndrome (MetSyn) in male and female
police oﬃcers from two study populations, Buﬀalo, NY and Spokane, WA. Depressive symptoms were measured using the Center
for Epidemiologic Studies-Depression (CES-D) scale. MetSyn was deﬁned using the 2005 AHA/NHBLI guidelines. Analysis of
covariance was used to describe diﬀerences in number of MetSyn components across depressive symptom categories. The number
of MetSyn components increased signiﬁcantly across categories of CES-D for Spokane men only (p-trend = 0.003). For each 5-
unit increase in CES-D score, odds increased by 47.6% for having hypertriglyceridemia, by 51.8% for having hypertension, and
by 56.7% for having glucose intolerance. Exploring this associationis important since both are predictors of future chronic health
problems and the results could be helpful in developing future gender-speciﬁc prevention and intervention eﬀorts among police
oﬃcers.
1.Introduction
Policeoﬃcersaremembersofauniqueoccupationalpopula-
tion whose exposure to potentially traumatic and life threat-
ening events is part of their professional duty [1]. Addi-
tionally,oﬃcersroutinelyencounterorganizational stressors,
such as court appearances, excessive paperwork, and shift
work [1]. Higher levels of perceived work stress have been
associated with depression among older police oﬃcers [2].
Police oﬃcers have more adverse cardiovascular disease
(CVD) risk factor levels and higher rates of CVD morbidity
and mortality compared to other populations [3–6]. Work
stress and depression are risk factors for the development of
CVD and diabetes [2, 7–20].
The MetSyn is a clustering of abnormalities (abdominal
obesity, hypertension, dyslipidemia, glucose intolerance)
that has been associated with increased risk for subclinical
atherosclerosis, CVD, diabetes, target organ damage, and
total mortality [21]. The association between depression and
the MetSyn has been studied over the past decade [8, 9, 11,
13, 14, 18, 19, 22–29], and more recently it has been sug-
gested that MetSyn may be intermediate in the pathway
between depression and CVD [11, 13, 15, 18, 19, 30,
31].Multiplepathophysiologicalmechanisms underlyingthe
association between depression and MetSyn have been pro-
posed. Onemechanism is neuroendocrineand involvesover-
stimulation of the hypothalamic-pituitary adrenal (HPA)
axis which leads to excess cortisol secretion and has been2 Journal of Environmental and Public Health
associated with both the development of depression and the
MetSyn components [32, 33]. Another indirect pathway is
throughadverse health behaviors associated with depression,
such ascigarettesmoking, excessive useofalcohol,and a sed-
entary lifestyle, which may be used as coping responses and
subsequently increase risk of MetSyn and CVD [8, 11, 19].
The association between depression and MetSyn appears
to be stronger in women, although the explanation for this
genderdiﬀerenceissomewhatunclear[11,15,18,23,25,26].
One possible explanation involves the role of sex hormones.
Overactivation of the HPA axis due to stress or depression
may result in decreased levels of sex hormones like estrogen
[34]. Decreased levels of estrogen, such as that occurs during
menopause, can elevate visceral fat mass, a component of
MetSyn [34].
Police oﬃcers are considered to be a relatively young and
presumably healthy occupational group (i.e., healthy worker
eﬀect);yettheysuﬀerfromhighlevelsofstressandCVD.The
purposeofthisstudy wastoexamine theassociation between
depressivesymptoms and theMetSynseparately among male
and female police oﬃcers from two cross-sectional studies.
No known studies were identiﬁed which examined this asso-
ciation in police oﬃcers. Participants are police oﬃcers from
two geographically diﬀerent locations, which may make the
ﬁndingsmoregeneralizabletoothergroupsofpoliceoﬃcers.
Basedontheliterature,thespeciﬁcstudyhypotheseswerethe
following: (1)depressivesymptoms wouldbeassociated with
a larger number of MetSyn components in male and female
police oﬃcers, (2) the association of depressive symptoms
with MetSyn and its components would diﬀer between male
and female police oﬃcers, and (3) the association between
depressive symptoms and MetSyn would not diﬀer by geo-
graphic location.
2.Methods
Participants included those from two studies at two separate
locations: Buﬀalo, New York and Spokane, Washington.
2.1. Buﬀalo Cardio-Metabolic Occupational Police Stress
(BCOPS)Study. TheBuﬀaloCardio-MetabolicOccupation-
al Police Stress (BCOPS) Study, a cross-sectional study of
urban policeoﬃcers, was conductedbetween2004and 2009.
The purpose of the BCOPS Study was to examine the associ-
ation between police stressors and physiological and psycho-
logical health consequences. The Center for Health Research
at the School of Public Health and Health Professions, State
University of New York in Buﬀalo, NY served as the data
collection site. All 710 active duty police oﬃcers from the
Buﬀalo, NY, Police Department were invited to participate
and the recruitment was ongoing for ﬁve years. No speciﬁc
inclusion criteria were used for the study, other than that the
participantbeaswornpoliceoﬃcerandwillingtoparticipate
in the study. Women oﬃc e r sw h ow e r ep r e g n a n ta tt h et i m e
of examination were excluded (n = 2). All participants pro-
videdinformedconsentandallphases,testing,andreportsof
the study were approved by the State University of New York
at Buﬀalo Internal Review Board and the National Institute
for Occupational Safety and Health Human Subjects Review
Board. Of the 464 oﬃcers examined, 54 were removed from
analyses (33 retired, 1 missing demographic information, 3
missing depressive symptoms, 17 missing MetSyn) leaving a
ﬁnal sample of 410 oﬃcers (304 men, 106 women; age range
21–66).
Questionnaires were administered to collect demograph-
ic and lifestyle information and psychosocial measures.
Participants provided a medical history (including history
of CVD) and a 12-hour fasting blood sample was collected
by a certiﬁed phlebotomist. Medication use was ascertained
through self-report and by inventory of current medications
brought to the clinic. Blood parameters for the MetSyn were
measuredbystandardlaboratorytechniquesontheBeckman
Coulter LX20 clinical chemistry analyzer and included a
blood lipid panel for high-density lipoprotein cholesterol
(HDL-C) and triglycerides and chemistry panels for glucose
[35]. Anthropometric measures were conducted by trained
clinic personnel. Waist circumference was measured as
abdominal girth at the highest point of the iliac crest and
the lowest point of the costal margin in the mid-axillary
line. Blood pressure was determined using the average of the
second and third of three separate measurements of resting
systolicanddiastolicbloodpressureobtainedwithastandard
sphygmomanometer.
2.2. Spokane Heart Study (SHS). The Spokane Heart Study
(SHS) was a prospective, longitudinal study investigating the
natural history of preclinical atherosclerosis. Details of the
study have previously been reported [4]. Over a 12-year
period, over 1,000 asymptomatic men and women were en-
rolled and followed every two years, generating an extensive
data set of medical and lifestyle histories, blood and urine
measurements, and Electron Beam Computed Tomography
(EBCT) measures of coronary artery calciﬁcation. At base-
line, all participants completed a comprehensive question-
naire which measured key behavioral, social, and lifestyle
domains. Fasting blood samples and anthropometric mea-
sures were taken prior to the EBCT scan. Routine assays for
blood chemistries, lipid proﬁle, and hematology were per-
formed [4]. The sample was almost equally divided between
men and women. All participants provided informed con-
sent and all phases, testing, and reports of the study were
approved by the Washington State University Institutional
Review Board. For the current study, data collection years
2003–2006,yearsmostcomparabletotheBCOPSstudy,were
used. Based on the questions, “what is the name of your
current employer” and “what is your current job title,” 134
police oﬃcers were identiﬁed. Of the 134 oﬃcers participat-
ing in the study, four were removed from analyses (two miss-
ing depressive symptoms and two missing MetSyn) leaving
a ﬁnal sample of 130 Spokane police oﬃcers (121 men, 9
women; age range 35–62).
2.3. Depressive Symptoms. In both studies, depressive symp-
toms were measured using the Center for Epidemiologic
Studies-Depression (CES-D) scale. The CES-D is a short 20-
itemscaledesignedtomeasure symptoms ofdepression(e.g.,
poor appetite, restless sleep, sadness) in the general popu-
lation on a 4-point scale [36] .T h e4 - p o i n ts c a l er e p r e s e n t sJournal of Environmental and Public Health 3
how much each symptom occurred during the past seven
days as follows: 0 (rarely or none of the time, less than 1
day), 1 (some or little of the time, 1-2 days), 2 (occasionally
or a moderate amount of time, 3-4 days), and 3 (most or
a l lo ft h et i m e ,5 – 7d a y s ) .T h eC E S - Di ss c o r e db yr e v e r s e
coding the appropriate items and summing the scores to
obtain an overall score. Respondents with scores between 0
and 15 are unlikely to be clinically depressed, scores of 16 to
21 indicate mild to moderate depression, and scores of 22 or
greater are associated with major depression [36]. The CES-
D has acceptable reliability, Cronbach alpha of 0.85, and a
split-half reliability ranging from 0.76 to 0.85 [34]. For the
current study, the continuous CES-D and three categories of
CES-D were used: low (0–8), middle (9–15), and high (16 or
greater).
2.4.MetSyn. The MetSyncriteria were based ontheNational
Cholesterol Education Program Adult Treatment Panel
guidelines with recent modiﬁcations from the American
Heart Association and the National Heart, Lung, and Blood
Institute [37]. The individual MetSyn components included
the following: (1) abdominal obesity (gender-speciﬁc waist
circumference ≥102cm in males, ≥88cm in females), (2)
hypertension (systolic blood pressure ≥ 130mmHg, dias-
tolic blood pressure ≥ 85mmHg, or reported physician-
diagnosedhypertensionandantihypertensive treatment),(3)
reduced HDL-C (gender-speciﬁc fasting HDL-C <40mg/dL
in men, <50mg/dL in women, or reported treatment with
nicotinic acid or ﬁbrates), (4) elevated triglycerides (fasting
triglycerides ≥ 150mg/dL, or reported treatment with nico-
tinic acid or ﬁbrates), and (5) glucose intolerance (fasting
serum glucose ≥ 100mg/dL, or reported treatment for dia-
betes). Participants were categorized according to the num-
ber of MetSyn components (0–5). MetSyn was considered
present in individuals with three or more components.
2.5. Statistical Methods. Descriptive statistics were used to
characterize the study population. The number of MetSyn
components and the prevalence of MetSyn and each indi-
vidual component were calculated. Analyses of variance and
covariancewereusedtoestimateanddescribetheunadjusted
and multivariate adjusted mean count of MetSyn compo-
nents across CES-D categories. Tests for trend were obtained
from linear regression analyses with continuous CES-D as
the independent variables and count of MetSyn components
as the dependent variable. Multivariate models were used
to adjust for age, smoking status, and marital status. These
covariates were chosen based on their association with de-
pression and MetSyn and evidence in the literature. Logistic
regression was used to calculate the odds for having each of
the ﬁve MetSyn components by categories of CES-D score.
Even though the tests of interaction for gender and location
(Buﬀalo, Spokane) were not statistically signiﬁcant, results
were stratiﬁed in order to provide comparisons between
locations and between male and female oﬃcers. All analyses
were conducted using the SAS software, Version 9.2 (SAS
Institute, Cary NC). Due to the small number of Spokane
women in this study, the primary analysis of the association
between CES-D and MetSyn could not be conducted in this
group; however, descriptive statistics for these nine partici-
pants are reported.
3.Results
3.1. Demographic Characteristics. Demographic characteris-
tics of the Buﬀalo, NY and Spokane, WA police oﬃcers are
shown in Table 1.T h eS p o k a n eo ﬃcers were between six and
eight years older than the Buﬀalo oﬃcers (Spokane range =
35–62, Buﬀalo range = 21–66) and nearly all white (1/130)
comparedtoapproximately22%ofBuﬀalooﬃcerswho were
black or Hispanic. More Spokane oﬃcers had completed at
least four years of college(44% versus34%) and the Spokane
men held higher ranks (abovepoliceoﬃcer) thanthe Buﬀalo
menorwomen(67.7%versus30.5%and19.8%,resp.).More
male oﬃcers were married (78.2% for Buﬀalo men, 91.7%
for Spokane men) than female oﬃcers (58.5% for Buﬀalo
women, 55.6% for Spokane women). More female Buﬀalo
oﬃcers were current smokers compared to the other three
groups.Themean(SD)CES-Dscorewas7.5(6.6)forBuﬀalo
men,6.6(5.5)forSpokanemen,8.7(8.2)forBuﬀalowomen,
and 5.8 (4.5) for Spokane women.
3.2. MetSyn and Its Components. The prevalence of each of
the MetSyn components tended to be higher for Spokane
oﬃcers compared to Buﬀalo oﬃcers (Table 2). The most
notablediﬀerenceswere thehigherprevalenceforabdominal
obesity, elevated triglycerides, and glucose intolerance in
Spokane women compared to Buﬀalo women. The diﬀer-
ences were not as large between Spokane and Buﬀalo men.
The mean values for each of the ﬁve MetSyn components
were higher for Spokane oﬃcers compared to Buﬀalo oﬃ-
cers, most notably triglyceride levels for Spokane women
(165.3mg/dL) compared to Buﬀalo women (88.4mg/dL).
The prevalence of MetSyn (≥3 components) was highest
among Spokane oﬃcers, 37.2% for men and 33.3% for
women, compared to Buﬀalo oﬃcers, 31.6% for men and
8.5% for women—half of the Buﬀalo women did not have
any of the MetSyn components. Accordingly, the number of
MetSyn componentswas higher among Spokane oﬃcers, 2.1
(1.4) for men and 1.7 (1.9) for women, compared to Buﬀalo
oﬃcers, 1.9 (1.4) for men and 0.9 (1.1) for women.
3.3. Association between Number of MetSyn Components and
Categories of CES-D Score. The unadjusted number of Met-
Syn components increased signiﬁcantly across categories of
CES-D for Spokane men (CES-D score 0–8 = 1.9 (1.3), 9–
15 = 2.6 (1.3), ≥16 = 3.1 (1.6), p-trend = 0.003) (Table 3).
This association remained signiﬁcant after adjustment for
age (p-trend = 0.004) and multivariate adjustment for age,
smoking, and marital status (p-trend = 0.003). No associa-
tion was found between number of MetSyn componentsand
CES-D score for Buﬀalo men or women. Similar analyses
could not be conducted for Spokane women due to the low
number of participants (n = 9). Excluding oﬃcers with
reported CVD or previous treatment for CVD (n = 11)
did not alter the associations appreciably (data not shown)4 Journal of Environmental and Public Health
Table 1: Demographic characteristics by location and gender.
Characteristic
Buﬀalo New York Police Oﬃcers (N = 410) Spokane Heart Study Police Oﬃcers (N = 130)
Men (N = 304) Women (N = 106) Men (N = 121) Women (N = 9)
N Mean (SD)
or % N Mean (SD)
or % N Mean (SD)
or % N Mean (SD)
or %
Age 304 40.8 (7.7) 106 40.8 (5.9) 121 49.1 (6.1) 9 47.3 (2.7)
<40 years 131 43.1 43 40.6 10 8.3 0 0.0
40–49 years 128 42.1 54 50.9 51 42.2 7 77.8
50+ years 45 14.8 9 8.5 60 49.6 2 22.2
Ethnicity
White 237 79.8 76 71.7 121 100.0 8 88.9
African American 53 17.9 30 28.3 0 0.0 0 0.0
H i s p a n i c 72 . 400 . 000 . 01 1 1 . 1
Education
<12 years, high school/GED 38 12.6 4 3.8 8 6.7 1 11.1
College <4 years 160 53.0 65 61.3 59 49.2 4 44.4
College 4+ years 104 34.4 37 34.9 53 44.2 4 44.4
Marital status
Single 29 9.6 23 21.7 0 0.0 3 33.3
Married 236 78.2 62 58.5 110 91.7 5 55.6
Divorced 37 12.3 21 19.8 10 8.3 1 11.1
Rank
Police oﬃcer 207 69.5 84 79.3 39 32.2 6 66.7
Sergeant/lieutenant/captain 51 17.1 11 10.4 47 38.8 1 11.1
Detective 34 11.4 9 8.5 28 23.1 2 22.2
Executive 5 1.7 1 0.9 7 5.8 0 0.0
Other 1 0.3 0 0.0 0 0.0 0 0.0
Smokingstatus
Current 40 13.2 28 27.2 4 3.3 1 11.1
Former 64 21.2 31 30.1 40 33.1 2 22.2
Never 199 65.7 44 42.7 77 63.6 6 66.7
Body mass index, kg/m2 304 30.3 (4.2) 106 26.0 (4.7) 124 29.8 (3.9) 9 28.9 (4.6)
<25 23 7.6 53 50.0 5 4.1 0 0.0
25–30 137 45.1 36 34.0 65 53.7 7 77.8
>30 144 47.4 17 16.0 51 42.2 2 22.2
CES-D score 304 7.5 (6.6) 106 8.7 (8.2) 122 6.6 (5.5) 9 5.8 (4.5)
Low score: 0–8 203 66.8 68 64.2 88 72.7 7 77.8
Middle score: 9–15 70 23.0 21 19.8 22 18.2 2 22.2
High score (depression): 16+ 31 10.2 17 16.0 11 9.1 0 0.0
nor did excluding oﬃcers taking antidepressant medications
(available for Buﬀalo police oﬃcers only, n = 32) (data not
shown). Separate analyses excluding Buﬀalo female oﬃcers
taking exogenous estrogen (birth control medication: n = 20
or hormone replacement medication: n = 4) also did not
alter the association (data not shown).
3.4. Odds Ratios for Individual MetSyn Components by CES-
DS c o r e .Odds ratios were calculated for having each indi-
vidual MetSyn component by CES-D score for Spokane men
(Table 4). For each 5-unit increase in CES-D score, the odds
of having abdominal obesity increased by 42%. Multivariate
adjustment for age, smoking, and marital status slightly at-
tenuated the association (OR = 1.338, 95% CI = 0.932–
1.917). For each 5-unit increase in CES-D score, the multi-
variate adjusted odds increased by 47.6% for having elevated
triglycerides (OR = 1.476, 95% CI = 1.025–2.119), by 56.7%
for having glucoseintolerance (OR = 1.567, 95% CI = 1.056–
2.327), and by 51.8% for having hypertension (OR = 1.518,
95% CI = 1.035–2.221).Journal of Environmental and Public Health 5
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Table 3: Unadjusted and adjusted number of metabolic syndrome components by categories of CES-D score by location and gender.
Categories of CES-D
Number of metabolic syndrome components
Unadjusted Age-adjusted Multivariate adjusted∗
N Mean (SD) P value∗∗ N Mean (SD) P value∗∗ N Mean (SD) P value∗∗
Buﬀalo men
0–8 203 1.8 (1.4) 203 1.8 (0.1) 202 1.9 (0.1)
9–15 70 2.2 (1.3) 0.431 70 2.2 (0.2) 0.379 69 2.3 (0.2) 0.390
≥16 31 1.9 (1.5) 31 2.0 (0.2) 31 2.0 (0.3)
Buﬀalo women
0–8 68 0.8 (1.1) 68 0.8 (0.1) 65 0.8 (0.1)
9–15 21 1.1 (1.4) 0.376 21 1.1 (0.2) 0.377 21 1.2 (0.3) 0.610
≥16 17 0.9 (0.9) 17 0.9 (0.3) 17 0.7 (0.3)
Spokane men
0–8 88 1.9 (1.3) 88 1.9 (0.1) 88 1.8 (0.3)
9–15 22 2.6 (1.3) 0.003 22 2.6 (0.3) 0.004 21 2.7 (0.4) 0.003
≥16 11 3.1 (1.6) 11 3.0 (0.4) 11 3.0 (0.5)
∗Adjusted for age, smoking status,and marital status.
∗∗P values are based on the continuous CES-D score.
Table 4: Unadjusted and adjusted odds ratios∗ for MetSyn components by CES-D score for Spokane men.
MetSyn component
Unadjusted (N = 121) Age-adjusted (N = 121) Multivariate adjusted∗∗ (N = 120)
Odds ratio 95% CI Odds ratio 95% CI Odds ratio 95% CI
Abdominal Obesity 1.422 1.010–2.003 1.396 0.985–1.977 1.338 0.932–1.917
Elevated Triglycerides 1.364 0.970–1.917 1.449 1.020–2.064 1.476 1.025–2.119
Reduced HDL-C 0.975 0.699–1.357 1.010 0.718–1.416 1.030 0.730–1.456
Glucose Intolerance 1.553 1.088–2.202 1.456 1.005–2.119 1.567 1.056–2.327
Hypertension 1.396 0.985–1.968 1.370 0.965–1.942 1.518 1.035–2.221
∗Odds ratios for having each metabolic syndrome component are based on a 5-unit change in CES-D score.
∗∗Adjusted for age, smoking status,and marital status.
4.Discussion
One surprising ﬁnding of this study was the low CES-D
scores in all groups (range 5.8–8.7) with between 64.2% and
77.8% of participants scoring in the low category (0–8). This
restricted range may have made the ﬁnding of a statistical
association with MetSyn less likely. However, the prevalence
of depression as indicated by a CES-D score ≥16 was com-
parable with that reported in the Framingham Heart Study
(10% in men, 17% in women): 9.1% for Spokane men,
10.2% for Buﬀalo men, and 16% for Buﬀalo women, and
the prevalence of MetSyn was notably higher for Spokane
men and women and Buﬀalo men (range 31.6%–37.2%)
compared to a recent study of US protective service workers
(26.1%) [38, 39].
An association between depressive symptoms and num-
ber of MetSyn components was observed for male Spokane
oﬃcers, partially supporting two of the study hypotheses:
depression would be associated with a higher number of
MetSyn components, and the association would be diﬀerent
between male and female police oﬃcers. The association
between depressive symptoms and MetSyn found for the
Spokane men extends to depressive symptoms in a nonclini-
calrange(i.e.,CES-D<16)[11].Previousstudieshavefound
similar ﬁndings in the association between depression and
MetSyn among a general population, among young and
middle-aged women, among adult male twins, and among
those at risk for CVD [11, 13, 22, 26, 28, 40, 41]. One study,
noting the peculiarity of their ﬁnding, found an association
between depressive symptoms and MetSyn in men but not
in women [42]. Interestingly, the association found in the
current study was signiﬁcant only among the male oﬃcers at
one location,Spokane,indicating that theremay be potential
factors not measured in thisstudy that couldhave inﬂuenced
the results, including traditional CVD risk factors such as
physical activity and diet,andemerging CVD risk factors like
inﬂammation and work stress [4, 20].
It is noteworthy that the Spokane oﬃcers were older and
heldhigherranksthantheBuﬀalooﬃcers.Whentheassocia-
tionbetween depressivesymptoms and MetSynwas stratiﬁed
on these two demographic variables, the association was
strongest among the older (>49 years, n = 59) versus
younger Spokane men (≤49, n = 61), and lower-ranking
(patrol oﬃcer, n = 39) versus higher ranking Spokane men
(n = 81) (data not shown). Yet, due to the small sample sizes
for the stratiﬁed analyses the ﬁndings are reported with cau-
tion. Lower ranking police oﬃcers may experience high job
demand and low job control. Perceived work stress has been
associated with depression among older mostly male police
oﬃcers, and high job strain has been signiﬁcantly associatedJournal of Environmental and Public Health 7
with depression among a national sample of working men
[2, 43]. Vitaliano et al. suggested that chronic stress leads
to depression which increases the risk of MetSyn and sub-
sequently CVD [20].
For Spokane men, the odds of having four of the Met-
Syn components (abdominal obesity, hypertriglyceridemia,
hypertension, glucose intolerance) increased by at least 40%
for every 5-unit increase in CES-D score. The association
with abdominal obesity was slightly attenuated by adjust-
ment for age, smoking status, and marital status,while HDL-
C was not associated with depressive symptoms. This ﬁnding
is supported by previous studies which have found depres-
sion to be associated with abdominal obesity, hypertriglyc-
eridemia, hypertension, and glucose intolerance [11, 19, 29,
40, 44, 45]. The association between depression and Met-
Syn and its components among these diverse populations
suggests that the pathophysiology of both conditions may
overlap; yet the biologic mechanisms may vary by MetSyn
component. Several potential mechanisms could be consid-
ered [46].
Dysfunction of the hypothalamic-pituitary-adrenal
(HPA) axis has been the most commonly cited mechanism
for the association between depression and MetSyn [29, 46].
Fruehwald-Schultes et al. have shown that hyperinsulinemia
activates the HPA axis and increases cortisol secretion
[47] and this increase has been associated with depres-
sion, the MetSyn, and its individual components [11, 17,
32, 33, 46, 48]. Second, inﬂammation particularly elevated
levels of C-reactive protein (CRP) have been associated with
depressive symptoms in younger men, and in elderly men
and women [49]. Inﬂammation has also been acknowledged
as a key factor underlying development of MetSyn [22, 46].
Finally, as a means of coping depressed individuals may
engage in poorhealth behaviors, such as a sedentary lifestyle,
poor nutrition, cigarette smoking, excessive alcohol intake,
or inadequate sleep, and these behaviors may lead to the
development of MetSyn [11, 19]. Of these behaviors, only
smoking status was available in the current study and it was
the Buﬀalo women who had the highest percent of current
and former smokers (57.3%) compared to the other groups
(all less than 37%). However, consistent with previous
studies, smoking status was included as a potential covariate
in multivariate analyses although adjustment attenuated the
association minimally across all groups.
Severallimitationsofthestudyshouldbenoted.First,the
CES-D provides a self-report measure of depressive symp-
toms as opposed to measuring clinical depression. Underre-
porting depressive symptoms is of concern with this occu-
pational group as oﬃcers may not wish to disclose sensitive
information. However, the CES-D has been widely used as a
measure for assessing depressive symptoms in epidemiologi-
cal studies. Second, this study was cross-sectional; therefore,
wecannotdeterminewhetherdepressivesymptomspreceded
the development of MetSyn and its components or make
causal inferences. Others have reported that the MetSyn may
lead to depression, speciﬁcally that hyperglycemia increases
HPA axis activity causing arousal of the central nervous
system thereby promoting development of depression [42].
Third, it ispossible thatparticipants in these twostudiesmay
not be representative of their respective police departments.
However, for the Buﬀalo study comparisons between study
participants and the Buﬀalo, NY Police Department resulted
in similar frequency distributions for sex, age, and police
rank.Finally,dataarefromtwostudiesofpoliceoﬃcers,thus
potentially limiting the generalizability of the study ﬁndings
to other police departments and other emergency responder
populations.
Oneofthestrengthsofthecurrentstudywastheabilityto
examine the association between depressive symptoms and
MetSyn separately for men and women oﬃcers. A signiﬁcant
relationship has frequently been found among women with
mixed results in men. Female police oﬃcers are an under-
studied occupational group and previous studies of police
oﬃcers have typically included only male oﬃcers. Second,
the study population was relatively young (mean age 49 for
Spokane, 41 for Buﬀalo) and we were able to exclude those
who have CVD or have received clinical interventions for
CVD, enabling us to aﬃrm that the relationship was unlikely
attributableto CVD[11].Third, we were ableto excludeoﬃ-
cers who were taking antidepressant medications and female
oﬃcers who reported taking exogenous estrogen, although
these exclusions did not alter the study ﬁndings. Finally,
we used a highly standardized measure as our outcome,
MetSyn [37]. In this study MetSyn was deﬁned as the count
of the number of components for each individual instead of
limiting the assessment to presence/absence of MetSyn for
the current study. This approach provides an interpretable
measure of association and is more sensitive in the detection
of associations [50].
In summary, depressive symptoms were associated with
an increasing number of MetSyn components and with
higher odds of having the individual MetSyn components
among Spokane male police oﬃc e r s .T h i si st h eﬁ r s ts t u d y
that we are aware of which has examined this relationship in
police oﬃcers. Yet, it is particularly important to understand
the association between depression and MetSyn among
police oﬃcers given the high-stress nature of their job and
the higher prevalence of CVD. Future studies should explore
potential mediators for this association, including the role
of the HPA axis and cortisol, inﬂammatory processes, and
hyperinsulinemia, asthesehavebeencitedaspotentialmech-
anisms by others. It is also important to explore the gender-
speciﬁc diﬀerences between male and female police oﬃcers.
Depressive symptomatology and MetSyn are early indicators
of future chronic health problems and the results could assist
in the development of future gender-speciﬁc prevention and
intervention eﬀorts among police oﬃcers.
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